Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Shield Therapeutics PLC
LSE:STX
Shield Therapeutics PLC
LSE:STX
Price:
3.15
GBX
-42.73%
Market Cap:
£33.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shield Therapeutics PLC
LSE:STX
|
UK |
Wall St Price Targets
STX Price Forecast
Based on 6 analysts
Based on 6 analysts
+386% Upside
from
3.15 GBX
today
Shield Therapeutics PLC (STX)’s 12-month stock price forecast through November 2027 has a consensus target of 15.3 GBX, implying 386% upside. The forecast is based on price targets from 6 Wall Street analysts.
STX Analyst Rating
No ratings yet
No ratings yet
Shield Therapeutics PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STX's stock price target?
Price Target
15.3
GBX
15.3
GBX
According to Wall Street analysts, the average 1-year price target for STX is 15.3 GBX with a low forecast of 12.12 GBX and a high forecast of 24.15 GBX.
What is the Revenue forecast for Shield Therapeutics PLC?
Projected CAGR
28%
28%
The compound annual growth rate for Revenue over the next 6 years is 28%.
What is the Gross Profit forecast for Shield Therapeutics PLC?
Projected CAGR
32%
32%
The compound annual growth rate for Gross Profit over the next 6 years is 32%.